Neurogene (NASDAQ:NGNE) Price Target Raised to $72.00 at Leerink Partners
Neurogene (NASDAQ:NGNE – Free Report) had its price target hoisted by Leerink Partners from $45.00 to $72.00 in a research report released on Tuesday,Benzinga reports. Leerink Partners currently has an outperform rating on the stock. Several other analysts also recently weighed in on the company. Robert W. Baird boosted their target price on Neurogene from […]
More Stories
Virpax Pharmaceuticals Receives Nasdaq Panel Decision, Granted Listing Continuation with Conditions
On January 6, 2025, Virpax Pharmaceuticals, Inc. announced in a Form 8-K filing that it had received a decision from...
Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors
Dallas, Texas, January 8, 2025 – Mangoceuticals, Inc. (NASDAQ:MGRX) recently disclosed in a Form 8-K filing with the Securities and...
**MedTech Acquisition Announces Leadership Transition and Salary Investment Program**
MedTech Acquisition (OTCMKTS:MTACU) recently disclosed its current report with the Securities and Exchange Commission (SEC) dated January 4, 2025. The...
CJM Wealth Advisers Ltd. Raises Stock Holdings in The Home Depot, Inc. (NYSE:HD)
CJM Wealth Advisers Ltd. boosted its holdings in The Home Depot, Inc. (NYSE:HD – Free Report) by 4.8% during the...
Eagle Point Income (NYSE:EIC) Upgraded at B. Riley
B. Riley upgraded shares of Eagle Point Income (NYSE:EIC – Free Report) to a strong-buy rating in a research note...
Burlington Stores (NYSE:BURL) Stock Rating Upgraded by UBS Group
Burlington Stores (NYSE:BURL – Get Free Report) was upgraded by research analysts at UBS Group from a “neutral” rating to...